Research and innovation in internet of things in the clinical trial operations sector has declined in the latest quarter ending May.
The most recent figures show that the number of IoT related patent applications in the industry stood at 72 in the three months ending May – down from 93 over the same period in 2021.
Figures for patent grants related to IoT followed a similar pattern to filings – shrinking from 29 in the three months ending May 2021 to 28 in the same period in 2022.
The figures are compiled by GlobalData, who track patent filings and grants from official offices around the world. Using textual analysis, as well as official patent classifications, these patents are grouped into key thematic areas, and linked to key companies across various industries.
IoT is one of the key areas tracked by GlobalData. It has been identified as being a key disruptive force facing companies in the coming years, and is one of the areas that companies investing resources in now are expected to reap rewards from.
The figures also provide an insight into the largest innovators in the sector.
Johnson & Johnson was the top IoT innovator in the clinical trial operations sector in the latest quarter. The company filed 30 IoT related patents in the three months ending May. That was down from 62 over the same period in 2021.
It was followed by Roche with 19 IoT patent applications, Otsuka (6 applications), and Sartorius (6 applications).
